Key facts
- It has raised $22.3M; the latest was Later Stage VC ($6.8M) in Apr 2025.
- Notable investors include Nanjing Innovation Capital Group, Nanjing Industrial Development Fund, BGI Co-Win, Fosun Pharma, Guohai Innovation Capital Investment Management — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Burning Point Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Burning Point Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Burning Point Medical
Developer of pharmaceutical solutions designed for hypertensive and spastic pain disorders. The company's products aim to treat hypertension, relieve chest pain and spastic pains, enabling healthcare professionals to prescribe more effective treatments to their patients.
- Sector
- Healthcare
- HQ
- Nanjing, China
- Founded
- 2019
- Website
- bpbiopharm.com/
- Ownership
- Privately Held (backing)
Burning Point Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Burning Point Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Burning Point Medical in its N-PORT filings yet. We sweep new filings monthly.